Machnet Medical Robotics Introducing the New Spinoff in Medical Robots

Machnet Medical Robotics Introducing the New Spinoff in Medical Robots

September 13, 2019

Machnet Medical Robotics, gaining knowledge from the University of Twente is developing a medical robot for MRI-guided biopsies. The application is currently focussed on taking biopsies of early-stage breast cancer.

According to Jeroen Veltman, who works as a radiologist at Ziekenhuisgroep Twente and is also involved in the project of medical robot offers a range of benefits. “With this MRI compatible robot technology, the radiologist will be able to position a biopsy or treatment needle in a very accurate way. The role of MRI in diagnostics is increasing and patient’s personalised treatment plans require increasingly accurate diagnostics. This new development offers all kinds of possibilities to improve care. In addition to applications for the breast, it is to be expected that, for example, MRI-guided prostrate diagnostics and treatment or MRI-guided vascular interventions will also benefit.”

The foundation for the robot is gathered from the research group of Stefano Stramigioli, who works on the development of medical robots as a professor of Advanced Robotics. Machnet Medical Robotics will become the centre of expertise in Twente for the development of robotic applications in radiology.

Nico Arfman, director of Machnet, will head the company. “In the coming years, we will develop the existing prototype into a certified medical device that is ready for the medical market. To so, we are putting together a team, further substantiating our business plan and looking for funding for these follow-up steps. This new company offers opportunities for cooperation with researchers, students and radiologists on the development of ground-breaking applications in the field of radiology.”

Source: University of Twente

Author : Meha Prasad

Tags :

IndustryHealthcare
x

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy and Cookie Policy. By continuing to use this site or closing this box, you consent to our use of cookies! Accept